Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection
Clinical trial NCT02346721 · COMPLETED
Trial details
- NCT number
- NCT02346721
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-23
- Primary completion
- 2016-03-23
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.